Yi Ding,Juan Yu,Jin-Yan Zhang et al.
Yi Ding et al.
A 47-year-old man with idiopathic mesenteric phlebosclerosis presented to our hospital because of a 2-month history of diarrhea and edema of both lower limbs. Contrastenhanced abdominal computed tomography (CT) showed a 2-cm mass of mixed d...
Association of mitotic checkpoint regulator MAD2L1 with fibrosis progression in chronic hepatitis C patients [0.03%]
MAD2L1(着丝点分离调节蛋白)基因与慢性丙型肝炎患者肝纤维化进展的关系研究
Saira S Khalid,Ayman A Abdo,Waleed Al-Hamoudi et al.
Saira S Khalid et al.
Direct intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosystemic shunt (TTIPS) to treat complications of portal hypertension: Indications, technique, and outcomes beyond Budd-Chiari syndrome [0.03%]
直接经肝 portocaval 分流(DIPS)或经颈静脉肝内门体分流(TTIPS)治疗门脉高压并发症：布加综合征以外的适应证、技术和预后研究
Florent Artru,Eleni Moschouri,Alban Denys
Florent Artru
Transjugular intrahepatic portosystemic shunt (TIPS) is nowadays the benchmark treatment of severe portal hypertension complications. However, besides usual contraindication to the procedure (namely recurrent hepatic encephalopathy, severe ...
Drug-eluting bead transarterial chemoembolization followed by apatinib is effective and safe in treating hepatocellular carcinoma patients with BCLC stage C [0.03%]
载药微球TACE联合阿帕替尼治疗BCLC C期肝细胞癌患者有效且安全
Shuguang Ju,Wenhui Wang,Pengfei Chen et al.
Shuguang Ju et al.
Background: The present study aimed to evaluate the efficacy and safety of drug-eluting beads transarterial chemoembolization (DEB-TACE) followed by apatinib in treating hepatocellular carcinoma (HCC) patients with Barcel...
Impact of recommendations and new therapies on the prognosis of colon cancer with synchronous liver metastasis [0.03%]
术前评估、治疗推荐和新疗法对同时性肝转移结肠癌预后的影响
Frederic Borie,Vincent Dubray,Brigitte Tretarre
Frederic Borie
Objective: To assess the prognostic impact of the new therapies recommended over the past twenty years for colonic cancers with synchronous hepatic metastasis (hmCC). ...
Surgical treatment of digestive cancer in a well-defined elderly population [0.03%]
选择性胃癌手术治疗的适应证及手术方式的选择
Antoine Latrille,Anne-Marie Bouvier,Valérie Jooste et al.
Antoine Latrille et al.
Introduction: Digestive cancer is of concern because of its frequency and severity with an increasing older median age of onset. The purpose of this study was to describe in a well-defined population presenting with non-m...
Fatal myositis and myasthenia induced by atezolizumab for the treatment of hepatocellular carcinoma [0.03%]
阿特朱单抗治疗肝细胞癌诱发的重症肌炎和肌无力一例
Jérôme Dumortier,Marie Simon,Françoise Bouhour
Jérôme Dumortier
Comparison of Transient Elastography, ShearWave Elastography, Magnetic Resonance Elastography and FibroTest as routine diagnostic markers for assessing liver fibrosis in children with Cystic Fibrosis [0.03%]
检测囊性纤维化儿童肝纤维化的常规超声弹性成像、磁共振弹性成像和Fibrotest对比研究
Jérémy Dana,Muriel Girard,Stéphanie Franchi-Abella et al.
Jérémy Dana et al.
Background and objective: Reliable markers are needed for early diagnosis and follow-up of liver disease in Cystic Fibrosis (CF). The objective was to evaluate the diagnostic performance of Transient Elastography (TE), Re...
Gemcitabine-facilitated modulation of the tumor microenvironment and PD-1/PD-L1 blockade generate a synergistic antitumor effect in a murine hepatocellular carcinoma model [0.03%]
吉西他滨联合PD-1/PD-L1抑制剂治疗协同抑制小鼠肝癌模型肿瘤生长并重塑肿瘤微环境
Hua Wang,Xue He,Dong Fang et al.
Hua Wang et al.
Background: Gemcitabine can alter the immunogenic microenvironments, and the effect of gemcitabine plus programmed death-1 (PD-1)/ programmed death-ligand 1 (PD-L1) blockade in hepatocellular carcinoma (HCC) is investigat...
Ji Li,Wei-Feng Huang,Jin-Yan Zhang
Ji Li